Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Farr

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Respiratory Medicine|November 4, 2000
Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study GroupB M Farr, C L Bartlett, J Wadsworth, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1984
Intranasal interferon-alpha 2 for prevention of natural rhinovirus coldsB M Farr, J M Gwaltney, K F Adams, et al.
Thorax|December 1, 1989
Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research SubcommitteeB M Farr, D L Kaiser, B D Harrison, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 2, 2000
Glove leakage rates as a function of latex content and brand: caveat emptorC A Muto, M G Sistrom, B A Strain, et al.
American Journal of Epidemiology|November 1, 1988
Two randomized controlled trials of virucidal nasal tissues in the prevention of natural upper respiratory infectionsB M Farr, J O Hendley, D L Kaiser, et al.
Cancer|March 15, 1995
Risk factors for infection of adult patients with cancer who have tunnelled central venous cathetersP B Howell, P E Walters, G R Donowitz, et al.
American Journal of Infection Control|April 5, 2001
Pseudoepidemic of streptococcal pharyngitis in a hospital pharmacyT B Karchmer, A M Anglim, L J Durbin, et al.
Infection Control and Hospital Epidemiology|August 14, 1998
Frequency of percutaneous injuries requiring postexposure prophylaxis for occupational exposure to human immunodeficiency virusM G Sistrom, B J Coyner, J M Gwaltney, et al.
The Journal of Hospital Infection|July 2, 2002
Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureusT B Karchmer, L J Durbin, B M Simonton, et al.
The Lancet. Infectious Diseases|March 2, 2002
Can antibiotic-resistant nosocomial infections be controlled?B M Farr, C D Salgado, T B Karchmer, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Respiratory Medicine|November 4, 2000
Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study GroupB M Farr, C L Bartlett, J Wadsworth, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1984
Intranasal interferon-alpha 2 for prevention of natural rhinovirus coldsB M Farr, J M Gwaltney, K F Adams, et al.
Thorax|December 1, 1989
Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research SubcommitteeB M Farr, D L Kaiser, B D Harrison, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 2, 2000
Glove leakage rates as a function of latex content and brand: caveat emptorC A Muto, M G Sistrom, B A Strain, et al.
American Journal of Epidemiology|November 1, 1988
Two randomized controlled trials of virucidal nasal tissues in the prevention of natural upper respiratory infectionsB M Farr, J O Hendley, D L Kaiser, et al.
Cancer|March 15, 1995
Risk factors for infection of adult patients with cancer who have tunnelled central venous cathetersP B Howell, P E Walters, G R Donowitz, et al.
American Journal of Infection Control|April 5, 2001
Pseudoepidemic of streptococcal pharyngitis in a hospital pharmacyT B Karchmer, A M Anglim, L J Durbin, et al.
Infection Control and Hospital Epidemiology|August 14, 1998
Frequency of percutaneous injuries requiring postexposure prophylaxis for occupational exposure to human immunodeficiency virusM G Sistrom, B J Coyner, J M Gwaltney, et al.
The Journal of Hospital Infection|July 2, 2002
Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureusT B Karchmer, L J Durbin, B M Simonton, et al.
The Lancet. Infectious Diseases|March 2, 2002
Can antibiotic-resistant nosocomial infections be controlled?B M Farr, C D Salgado, T B Karchmer, et al.
Pageof 8